September 18, 2013 3:36 am
Alemtuzumab
Sanofi and its subsidiary Genzyme have been given marketing approval by the European Commission for Lemtrada (alemtuzumab), a treatment for multiple sclerosis. read all at
click on title below
Genzyme’s multiple sclerosis treatment approved by European Commission
Posted by DR ANTHONY MELVIN CRASTO Ph.D
Categories: EU PIPELINE, EU SUBMISSION
Tags: alemtuzumab, Anthony crasto, drugs, EU, EU SUBMISSION, fda, GENERIC DRUG, GMP, lemtrada, medicinal chemistry, NEW DRUGS, organic chemistry, world drug tracker
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.